• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[The guideline of the diagnosis and treatment of mantle cell lymphoma in China (2022)].

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2022 Jul 14;43(7):529-536. doi: 10.3760/cma.j.issn.0253-2727.2022.07.001.

DOI:10.3760/cma.j.issn.0253-2727.2022.07.001
PMID:36709128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9395568/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c534/9395568/3ebb49667fd9/cjh-43-07-529-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c534/9395568/d7a2b03ca837/cjh-43-07-529-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c534/9395568/3ebb49667fd9/cjh-43-07-529-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c534/9395568/d7a2b03ca837/cjh-43-07-529-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c534/9395568/3ebb49667fd9/cjh-43-07-529-g002.jpg

相似文献

1
[The guideline of the diagnosis and treatment of mantle cell lymphoma in China (2022)].《中国套细胞淋巴瘤诊疗指南（2022年版）》
Zhonghua Xue Ye Xue Za Zhi. 2022 Jul 14;43(7):529-536. doi: 10.3760/cma.j.issn.0253-2727.2022.07.001.
2
[Interpretation of the guidelines for diagnosis and treatment of mantle cell lymphoma in China (2022)].《中国套细胞淋巴瘤诊断与治疗指南（2022年版）》解读
Zhonghua Xue Ye Xue Za Zhi. 2022 Nov 14;43(11):903-909. doi: 10.3760/cma.j.issn.0253-2727.2022.11.004.
3
Transformation of indolent mantle cell lymphoma to pleomorphic mantle cell lymphoma: case report and review of clinical and morphologic variants.惰性套细胞淋巴瘤向多形性套细胞淋巴瘤的转化：病例报告及临床和形态学变异型的复习。
Arch Pathol Lab Med. 2012 Aug;136(8):871-5. doi: 10.5858/arpa.2012-0197-CR.
4
Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.套细胞淋巴瘤：2015 年诊断、风险分层和临床管理更新。
Am J Hematol. 2015 Aug;90(8):739-45. doi: 10.1002/ajh.24094.
5
Mantle cell lymphoma in lymph nodes with metastatic small cell carcinoma of lung: a diagnostic and treatment dilemma.淋巴结中的套细胞淋巴瘤合并肺转移性小细胞癌：诊断与治疗困境
Leuk Lymphoma. 2004 Feb;45(2):409-14. doi: 10.1080/1042819031000149395.
6
Non-Hodgkin Lymphoma.非霍奇金淋巴瘤
Monogr Clin Cytol. 2018;23:34-51. doi: 10.1159/000478880. Epub 2017 Nov 13.
7
Mantle cell lymphoma: from ultrasound examination to histological diagnosis.套细胞淋巴瘤：从超声检查到组织学诊断
J Ultrasound. 2018 Dec;21(4):339-342. doi: 10.1007/s40477-018-0318-1. Epub 2018 Aug 21.
8
A rare involvement of epitrochlear lymph nodes in mantle cell lymphoma.套细胞淋巴瘤累及滑车上淋巴结罕见。
BMJ Case Rep. 2018 Apr 17;2018:bcr-2018-224665. doi: 10.1136/bcr-2018-224665.
9
[Pitfalls and update in haematopathology. Case 2. "Early phase" mantle cell lymphoma of the lymph node].[血液病理学的陷阱与进展。病例2。淋巴结“早期”套细胞淋巴瘤]
Ann Pathol. 2012 Oct;32(5):336-40. doi: 10.1016/j.annpat.2012.07.018. Epub 2012 Oct 22.
10
Stage I mantle-cell lymphoma that was difficult to differentiate from abdominal tuberculous lymphadenitis and metastatic pancreatic cancer.
J Gastroenterol. 2002;37(10):859-62. doi: 10.1007/s005350200142.

引用本文的文献

1
Case Report: Membranous nephropathy associated with mantle cell lymphoma: a rare case.病例报告：套细胞淋巴瘤相关的膜性肾病：1例罕见病例
Front Med (Lausanne). 2025 Aug 15;12:1627010. doi: 10.3389/fmed.2025.1627010. eCollection 2025.

本文引用的文献

1
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.T 细胞淋巴瘤，2.2022 年版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2022 Mar;20(3):285-308. doi: 10.6004/jnccn.2022.0015.
2
Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study.利妥昔单抗时代中国学术中心治疗的套细胞淋巴瘤患者的初始治疗模式及生存结果：一项真实世界研究
Front Oncol. 2022 Jan 4;11:770988. doi: 10.3389/fonc.2021.770988. eCollection 2021.
3
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.
基因组和转录组谱分析揭示与套细胞淋巴瘤患者结局相关的不同分子亚群。
J Clin Invest. 2022 Feb 1;132(3). doi: 10.1172/JCI153283.
4
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.伊布替尼联合利妥昔单抗用于初治老年套细胞淋巴瘤患者。
J Clin Oncol. 2022 Jan 10;40(2):202-212. doi: 10.1200/JCO.21.01797. Epub 2021 Nov 19.
5
Therapeutic options for relapsed/refractory mantle cell lymphoma.复发/难治性套细胞淋巴瘤的治疗选择。
Blood. 2022 Feb 3;139(5):666-677. doi: 10.1182/blood.2021013326.
6
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial.奥沙利铂在自体移植前联合大剂量阿糖胞苷和利妥昔单抗治疗套细胞淋巴瘤患者，比顺铂或卡铂提供更长的疾病控制时间：来自 LyMA 前瞻性试验的结果。
Bone Marrow Transplant. 2021 Jul;56(7):1700-1709. doi: 10.1038/s41409-020-01198-2. Epub 2021 Mar 3.
7
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy.新药和CAR-T细胞疗法时代套细胞淋巴瘤的异基因干细胞移植
Cancers (Basel). 2021 Jan 14;13(2):291. doi: 10.3390/cancers13020291.
8
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial.来那度胺维持治疗套细胞淋巴瘤自体造血干细胞移植后：一项意大利淋巴瘤基金会（FIL）多中心、随机、3 期临床试验结果。
Lancet Haematol. 2021 Jan;8(1):e34-e44. doi: 10.1016/S2352-3026(20)30358-6. Epub 2020 Dec 22.
9
High-Risk Mantle Cell Lymphoma: Definition, Current Challenges, and Management.高危套细胞淋巴瘤：定义、当前挑战及管理
J Clin Oncol. 2020 Dec 20;38(36):4302-4316. doi: 10.1200/JCO.20.02287. Epub 2020 Oct 19.
10
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study.初治复发/难治性年轻套细胞淋巴瘤患者的结局：MANTLE-FIRST 研究结果。
Leukemia. 2021 Mar;35(3):787-795. doi: 10.1038/s41375-020-01013-3. Epub 2020 Aug 11.